More News

21 Feb 2007 Roche and GSK agree on two transactions
21 Feb 2007 Hybrigenics Focuses its Research on Inhibitors of Ubiquitin-Specific Proteases in Cancer
21 Feb 2007 Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
21 Feb 2007 Genfit Extends Its Drug Discovery Strategic Alliances with Sanofi-Aventis and Solvay
20 Feb 2007 Entelos and Organon Extend Research Agreement
17 Feb 2007 OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
17 Feb 2007 InSite Vision Announces License Agreement With Inspire Pharmaceuticals
17 Feb 2007 Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
16 Feb 2007 Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
15 Feb 2007 Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
15 Feb 2007 Acambis signs JE partnership agreement with sanofi pasteur
15 Feb 2007 GW and Otsuka Announce Major Long Term Strategic Cannabinoid Alliance
15 Feb 2007 Halozyme and Baxter Expand Global HYLENEX Collaboration
15 Feb 2007 Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
14 Feb 2007 InSite Vision Announces Positive Top-Line Safety Results from Phase 1 AzaSite Plus Clinical Study
14 Feb 2007 Organon and Pharmacopeia Enter Into Discovery, Development and Commercialization Alliance
14 Feb 2007 Elixir Pharmaceuticals and Siena Biotech S.p.A. Enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease
14 Feb 2007 Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
13 Feb 2007 AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
13 Feb 2007 Adeza to Be Acquired by Cytyc for $24 Per Share
13 Feb 2007 Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
09 Feb 2007 GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
09 Feb 2007 Corautus Genetics and VIA Pharmaceuticals Announce Merger Agreement

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top